Avecho Biotechnology advances its Phase III insomnia capsule trial to full enrolment after a clean independent safety review.
What Is Putting Avecho Biotechnology (ASX:AVE) in Focus?
Avecho Biotechnology advances its Phase III insomnia capsule trial to full enrolment after a clean independent safety review.